touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing.
The experts
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/treatment-sequencing-in-ms-the-benefits-of-dmts/
MDT perspectives on established methods for managing DMD
MDT perspectives on novel pharmacological and gene therapies for patients with DMD
Understanding the pathophysiology of multiple sclerosis and the development of new therapies
Understanding the pathophysiology of multiple sclerosis and the development of new therapies
Emerging data with immunotherapy in ESCC and potential impact for clinical practice
Improving the alpha-mannosidosis patient journey
Improving the alpha-mannosidosis patient journey
Improving the alpha-mannosidosis patient journey
HER2 testing in colorectal cancer
Managing treatment side effects in HER2-positive colorectal cancer
Supporting patients with HER2-positive colorectal cancer
Utilizing HER2-targeted treatments in colorectal cancer
Navigating the complexities of the NSCLC treatment pathway: A focus on antibody-drug conjugates
Higher-risk MDS: An update on emerging novel agents
Supporting families to optimize outcomes
Supporting families to optimize outcomes
The role of the MDT in managing paediatric severe type 2 asthma
The role of the MDT in managing paediatric severe type 2 asthma
The use of biologics in children with severe type 2 asthma
The use of biologics in children with severe type 2 asthma
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain